1Matejuk A, Dwyer J, Ito A, et al. Effects of cytokine deficiency on chemokine expression in CNS of mice with EAE [ J ]. J Neurosci Res,2002,67 (5) :680 - 688.
2Nicoletti F, Marco RD, Mangano K. Increased serum levels of interleukin-18 in patients with multiple Sclerosis [ J]. Neurology,2001,57:342 - 344.
3Losy J, Niezgoda A. IL-18 in patients with multiple sclerosis [J]. Acta Neurol Stand,2001,104:171 - 173.
5Fassbender F, Mielke O, Bertsch J, et al. Interferon-r-inducing factor (IL-18) and interferon-r in inflammatory CNS diseases [ J ]. Neurology, 1999,53 : 1104 - 1106.
二级参考文献11
1Van der Aa A, Hellings N, Bernard CC, et al. Functional properties of myelin oligodendrocyte glycoprotein-reaetive T cells in multiple sclerosis patients and controls. J Neuroimmunol, 2003,137(1-2):164-176.
2Olesson T. Role of cytokines in multiple sclerosis and experimental allergic encephalomyelitis. Eur J Neuro, 1994,1(1):7-19.
3Matejuk A, Dwyer J, Ito A, et al. Effects of cytokine deficiency on chemokine expression in CNS of mice with EAE. J Neurosci Res, 20(12,67(5):680-688.
4Merrill J, Benveniste E. Cytokiines in inflammatory brain lesions: helpful and harmful. Trends Neurosci, 1996, 19(8): 165-177.
5Davidson TS, Hiekey WF. Antisecretory factor expression is regulated by inflammatory mediators and influences the severity of experimental autoimmune encephalomyelitis. J Lcukoc Biol,2004,76(4): 835-844.
6Barcellos LF, Dksenberg LF, Green AJ, et al. Genetic basis for clinical expression in multiple scterosis. J Brain, 2002,125(1):150-158.
7Zhang X, Koldzic DN, Izikson L, et al. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25 + CD4 + regulatory T cells. Int Immunol, 2004, 16(2) :249-256,
8Karni A, Koldzic DN, Bharanidharan P, et al. IL-18 is linked to raised IFN gamma in multiple sclerosis and is induced by activated CD4(+) T cells via CD40-CD40 ligand interactions. J Neuroimmunol, 2002,125(1-2): 134-140.
9Losy J, Niezagoda A. IL-18 in patients with multiple sclerosis.Acta Neurol Scand 2001,104(3): 171-173.
10Nagai T, Devergne O, Mueller TF, et al. Timing of IFN-beta exposure during human dendritic cell maturation and naive Th cell stimulation has contrasting effects on Th1 subset generation: a role for IFN-beta-mediated regulation of IL-12 family cytokines and IL-18 in naive Th cell differentiation. J Immunol,2003,171(10): 5233-5243.
4BossùP,Ciaramella A,Salani F,et al .Interleukin 18,from neu- roinflammation to Alzheimer’s disease [J]. Curr Pharm Des,2010,16(38):4213-4224.
5Soltani A,Clark WM,Hansmann DR,et al .Sonothrombolysis:anemerging modality for the treatment of acute ischemic and hem- orrhagic stroke[J].Transl Stroke Res,2011,2(2):159-170.
6Hedtj-rn M,Leverin AL,Eriksson K,et al . Interleukin 18 in- volvement in hypoxic ischemic brain injury [J]. J Neurosci,2002,22(14):5910-5919.
7Jander S,Stoll G.Differential induction of interleukin 12,inter-leukin 18,and interleukin 1beta converting enzyme mRNA inexperimental autoimmune encephalomyelitis of the Lewis rat[J].J Neuroimmunol,1998,91(1 2):93-99.
8Zaki MH,Vogel P,Body Malapel M,et al . IL 18 productiondownstream of the Nlrp3 inflammasome confers protection a- gainst colorectal tumor formation[J].J Immunol,2010,185(8):4912 4920.
9Kim KE,Song H,Hahm C,et al .Expression of ADAM33 is a no- vel regulatory mechanism in IL 18 secreted process in gastriccancer[J].J Immunol,2009,182(6):3548 -3555.
10Kang JS,Bae SY,Kim HR,et al .Interleukin 18 increases me- tastasis and immune escape of stomach cancer via the downreg- ulation of CD70 and maintenance of CD44[J].Carcinogenesis,2009,30(12):1987-1996.
